Martyna Sienicka

Martyna Sienicka

Auto-generated profile, based on publicly available information

Martyna Sienicka

Instytut „Centrum Zdrowia Matki Polki” w Łodzi, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JGJulia Gatniejewska
Julia Gatniejewska
MSMartyna Sienicka
Martyna Sienicka
PPPaulina Prudzic
Paulina Prudzic
WWWeronika Winiarska
Weronika Winiarska
WBWiktoria Bełcikowska-Skowron
Wiktoria Bełcikowska-Skowron
EPEmilia Przybyszewska
Emilia Przybyszewska
Introduction: Irritable bowel syndrome is characterized by symptoms such as abdominal pain associated with defecation and changes in stool frequency and/or consistency. In recent years, the low-FODMAP diet has become one of the most commonly used dietary interventions. Aim of the study: The aim of this study was to assess the effectiveness of the low-FODMAP diet and to identify its limitations and consistency with current guidelines. Methods: A narrative review of the literature was conducted, including 31 publications from 2012–2026, such as original research articles, randomized controlled trials, systematic reviews, meta-analyses, and current clinical guidelines on the diagnosis and treatment of IBS. PubMed and Google Scholar databases were searched using predefined inclusion and exclusion criteria. Main findings: The results of the analyzed studies indicate that the low-FODMAP diet may reduce IBS symptoms such as bloating, abdominal pain, and intestinal discomfort. However, no clear superiority over other dietary strategies has been demonstrated. Clinical response varies and may depend on the patient’s gut microbiota. Data on the use of the low-FODMAP diet in the pediatric population and other special clinical groups are limited and do not allow definitive conclusions to be drawn. Conclusions: The low-FODMAP diet is an effective therapeutic option in selected patients with IBS; however, it should be implemented in stages, including elimination, reintroduction, and personalization phases. Supervision by a dietitian and individual adjustment of recommendations to the patient’s needs are recommended. Further studies are needed to assess the long-term effects of the diet and predictors of clinical response.

20 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMartyna Sienicka
Martyna Sienicka
YDYuliia Dubova
Yuliia Dubova
IZIia Zhaharina
Iia Zhaharina
YMYaryna Manila
Yaryna Manila
AKAleksandra Kłus
Aleksandra Kłus
VDValery Doroshkov
Valery Doroshkov
Childhood and adolescent obesity represents a growing global public health challenge associated with numerous metabolic, behavioral, and psychosocial consequences. In recent years, digital health technologies have increasingly been implemented as tools supporting obesity prevention and management among pediatric populations. The aim of this systematic review was to evaluate the role and effectiveness of digital health interventions in the prevention and management of obesity among children and adolescents, with particular attention to intervention type, target population, measured outcomes, and social implications. A systematic literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, and PsycINFO in accordance with PRISMA 2020 guidelines. Original empirical studies published between 2010 and 2026 involving participants aged 2–18 years were included. A total of 22 original empirical studies published between 2010 and 2026 were included in the qualitative synthesis. The analyzed interventions comprised mobile health applications, telemedicine, internet-based educational programs, text-message interventions, and active video games. The included studies demonstrated that digital interventions may positively influence obesity-related outcomes, including body mass index (BMI), physical activity, dietary behaviors, self-monitoring, motivation, and adherence to lifestyle modification programs. Telemedicine and mobile health approaches additionally improved accessibility to obesity management services, particularly in underserved populations. Despite promising findings, considerable heterogeneity in study design, intervention duration, and outcome assessment was identified. Further large-scale longitudinal studies are needed to evaluate the long-term effectiveness and sustainability of digital obesity interventions among children and adolescents.

21 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
IZIia Zhaharina
Iia Zhaharina
YMYaryna Manila
Yaryna Manila
YDYuliia Dubova
Yuliia Dubova
AKAleksandra Kłuś
Aleksandra Kłuś
AKAneta Kasperska
Aneta Kasperska
VDValery Doroshkov
Valery Doroshkov
Chronic kidney disease (CKD) represents a substantial and growing global health dysfunction. The rising occurrence driven by aging populations and increasing rates of metabolic disorders. This disease causes kidney function to slowly get worse. In the early stages, there are often no symptoms, so it is usually diagnosed only after significant kidney damage has already happened. Current clinical and public health strategies prioritize early identification and risk reduction. Modifiable lifestyle factors - such as regular physical activity and effective weight management - play an important role in slowing disease progression and reducing the risk of end-stage renal disease requiring dialysis or kidney transplantation. This narrative review aims to investigate the relationship between physical activity and the slowing of chronic kidney disease progression in patients. This narrative review evaluates scientific literature published over the past 25 years. Relevant data were obtained from studies indexed in the PubMed and Scopus databases. Cohort studies, systematic reviews, and meta-analyses published in English were included. Across the analyzed studies, greater engagement in physical activity was consistently linked to lower all-cause mortality in patients with chronic kidney disease. Active individuals tended to report better quality of life and exhibited a more gradual reduction in kidney function compared to those with lower activity levels, which indicates that regular physical activity is associated with improved patient prognosis. Physical activity has been consistently connected to lower death rates in people with chronic kidney disease. In addition, higher levels of physical activity relate to better quality of life and a slower rate of disease progression when compared to inactive patients.

31 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AFAgnieszka Filarecka
Agnieszka Filarecka
PPPiotr Przybyszewski
Piotr Przybyszewski
EPEmilia Przybyszewska
Emilia Przybyszewska
JGJulia Gatniejewska
Julia Gatniejewska
MSMartyna Sienicka
Martyna Sienicka
MCMarzena Chrapczyńska
Marzena Chrapczyńska
Introduction: Bronchial asthma remains a significant clinical problem despite advances in pharmacological treatment. Approximately 5–10% of asthma patients suffer from a severe, uncontrolled form of the disease associated with frequent exacerbations, impaired lung function, reduced quality of life, and increased hospitalization rates. The introduction of biologic therapies targeting Th2-dependent inflammatory pathways has significantly improved treatment outcomes in this group of patients. Aim of the Study: The aim of this study was to analyze and compare the efficacy and safety of biologic therapies used in the treatment of severe asthma, with particular emphasis on tezepelumab, mepolizumab, benralizumab, and dupilumab, based on clinical trials and real-world studies. Materials and Methods: A literature review was conducted using the PubMed database. Original clinical trials, prospective studies, and real-world observational studies published between 2020 and 2026 were included in the analysis. The effects of biologic therapies on asthma exacerbation reduction, improvement in lung function, reduction in oral corticosteroid use, achievement of clinical remission, and long-term treatment safety were evaluated. Results: All analyzed biologic therapies demonstrated significant clinical efficacy in the treatment of severe asthma. Tezepelumab led to a substantial reduction in the number of exacerbations, improvement in pulmonary function parameters, and reduction in oral corticosteroid use regardless of eosinophil levels. Mepolizumab and benralizumab showed comparable efficacy, particularly in patients with eosinophilic asthma. Dupilumab demonstrated high efficacy in patients with type 2 inflammation, especially regarding improvement in lung function. Real-world studies confirmed the effectiveness and favorable safety profile of biologic therapies observed in randomized clinical trials. Conclusions: Biologic therapies constitute an effective and safe treatment option for severe asthma and significantly improve disease control and patients’ quality of life. The strongest clinical evidence concerns tezepelumab, mepolizumab, benralizumab, and dupilumab; however, treatment efficacy may depend on the disease phenotype and inflammatory biomarkers. Further studies are needed to optimize the personalization of biologic therapies and to standardize remission criteria in severe asthma.

18 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WBWiktoria Bełcikowska-Skowron
Wiktoria Bełcikowska-Skowron
ASAleksandra Siegmund
Aleksandra Siegmund
MCMarzena Chrapczyńska
Marzena Chrapczyńska
AFAgnieszka Filarecka
Agnieszka Filarecka
PPPiotr Przybyszewski
Piotr Przybyszewski
WWWeronika Winiarska
Weronika Winiarska
Childhood overweight and obesity remain major global public health challenges associated with increased cardiometabolic risk, psychosocial complications, and persistence into adulthood. Lifestyle interventions are considered the first-line strategy for obesity prevention and treatment in pediatric populations. The aim of this systematic review was to evaluate the effectiveness of lifestyle interventions in preventing and treating overweight and obesity among children and adolescents aged 0–18 years. A systematic literature review of randomized controlled trials published between January 2016 and March 2026 was conducted using PubMed and Google Scholar databases. Studies involving dietary, physical activity, behavioral, family-based, school-based, or technology-assisted interventions were included. Following screening and eligibility assessment, 39 randomized controlled trials were included in the narrative synthesis. Most interventions combined nutritional education, physical activity, behavioral strategies, and family or school involvement. Family-based and intensive multicomponent interventions demonstrated the most consistent improvements in body mass index (BMI) and health-related behaviors. School-based interventions generally improved lifestyle behaviors; however, their effects on anthropometric outcomes were less consistent. Technology-assisted interventions, including exergaming and wearable devices, produced mixed results. Several studies also reported improvements in metabolic parameters, physical activity, and quality of life despite modest BMI reductions. Overall, lifestyle interventions may support the prevention and treatment of childhood obesity, although their effects on BMI are generally moderate. The most effective interventions appear to be intensive, family-centered, and multicomponent. Future research should focus on long-term follow-up, implementation feasibility, and sustainable intervention strategies.

16 August 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMartyna Sienicka
Martyna Sienicka
WWWeronika Winiarska
Weronika Winiarska
WBWiktoria Bełcikowska-Skowron
Wiktoria Bełcikowska-Skowron
ASAleksandra Siegmund
Aleksandra Siegmund
MCMarzena Chrapczyńska
Marzena Chrapczyńska
PPPaulina Prudzic
Paulina Prudzic
Polycystic ovary syndrome (PCOS) is a multifaceted endocrine and metabolic condition affecting women of reproductive age. While historically conceptualized as a reproductive disorder, current evidence indicates that PCOS extends beyond ovulatory dysfunction and hyperandrogenism to include significant metabolic, psychological, and quality of life consequences. Insulin resistance represents a core pathophysiological feature of the syndrome, contributing to hyperinsulinemia, exacerbation of androgen excess, menstrual irregularities, and long term metabolic risk. This narrative review synthesizes current literature on the mechanisms and clinical implications of insulin resistance in PCOS, drawing from peer reviewed studies, systematic reviews, meta analyses, and international guidelines. Evidence shows that insulin resistance is prevalent across PCOS phenotypes, including in women without obesity, and is strongly associated with impaired glucose metabolism, dyslipidemia, metabolic syndrome, and increased cardiometabolic vulnerability. Psychological burden is also substantial, with many women reporting depressive and anxiety symptoms, body image concerns, fertility related distress, and reduced overall wellbeing. Interactions between metabolic dysfunction, emotional health, and lifestyle factors further contribute to diminished health related quality of life. Collectively, these findings highlight the need for early metabolic assessment, individualized therapeutic strategies, and interdisciplinary care models addressing both physiological and psychosocial dimensions of PCOS. A comprehensive approach to insulin resistance may improve reproductive, metabolic, and psychological outcomes and support more patient centered long term management.